Wiser Advisor Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-233
Closed -$81.8K 227
2025
Q4
$81.8K Buy
233
+1
+0.4% +$338 0.09% 75
2025
Q3
$75K Buy
+232
New +$72.2K 0.09% 75
2025
Q2
Sell
-230
Closed -$100K 106
2025
Q1
$100K Buy
230
+1
+0.4% +$401 0.15% 68
2024
Q4
$84.5K Buy
229
+108
+89% +$45.2K 0.12% 74
2024
Q3
$62.9K Hold
121
0.09% 85
2024
Q2
$65.4K Buy
121
+101
+505% +$53.4K 0.1% 78
2024
Q1
$10.5K Hold
20
0.02% 188
2023
Q4
$9.52K Buy
+20
New +$9.25K 0.02% 185

Other funds holding ELV

Wiser Advisor Group's ELV Position: Q1 2026 in Review

Wiser Advisor Group sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 233 shares — an estimated $81.8K sold.

Wiser Advisor Group first reported a position in ELV in Q4 2023 and held it in 8 quarters. The position peaked at $100K in Q1 2025. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Wiser Advisor Group reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Wiser Advisor Group sold 233 Elevance Health shares in Q1 2026, an estimated $81.8K.
  • Wiser Advisor Group first reported a position in Elevance Health in Q4 2023 and held it in 8 quarters.
  • Wiser Advisor Group's Elevance Health position peaked at $100K in Q1 2025.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Wiser Advisor Group's 13F filing for Q1 2026, filed 22 Apr 2026.